Search

everythinglearnresearchcommunity

for

Search:↓

Most people with scarring and nonscarring hair loss show similar D2-40 levels, but some with scarring hair loss have higher levels.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Researchers made a cell line that grows quickly and can help with hair growth research.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Keratin genes change gradually during skin cell development and should be used carefully as biomarkers.

Stem cells regenerate tissues and their behavior varies by environment, suggesting the hematopoietic system model may need revision.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Microspheres about 1.5 micrometers in size can best penetrate hair follicles, potentially reaching important stem cells.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

Keratins are important for skin cell health and their problems can cause diseases.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

Researchers created rat liver stem cells that could help repair liver failure in rats and may be useful for studying human liver diseases.

Nude mice with grafted human skin developed scars similar to human hypertrophic scars.

FoxN1 gene is essential for proper thymus structure and preventing hair loss.

Cat color patterns are determined early in development by gene expression and epidermal changes, with the Dickkopf 4 gene playing a crucial role.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

The study suggests that a new protease inhibitor can make hair harder to pull out, potentially reducing hair loss.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Human scalp fat stem cells showed improved cartilage-like development on a special scaffold with freeze-thaw treatment.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Hypothyroidism harms rat skin, but topical triiodothyronine may help improve it.

MPA increases cancer spread by boosting Eph A2 activity.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

β-catenin is essential for stem cell activation and proliferation in hair follicles.